Guoli Sun
Impact in
- Nephrology top 5%
- Acute Kidney Injury Research
- Pharmacology top 5%
- Berberine and alkaloids research
Papers in
- Nephrology 20
- Acute Kidney Injury Research 20
- Chronic Kidney Disease and Diabetes 2
- Co-authors
- Wenjie Zheng (1 shared paper)Jiarong Lan (1 shared paper)Feixia Dong (1 shared paper)Yanyun Zhao (1 shared paper)Yong Liu (23 shared papers)Shiqun Chen (22 shared papers)Jiyan Chen (19 shared papers)Jin Liu (16 shared papers)
- Journals
- Annals of Translational Medicine (4 papers)BMC Cardiovascular Disorders (2 papers)Journal of Internal Medicine (2 papers)Trials (2 papers)BMJ Open (2 papers)
- Partner nations
- ChinaUnited StatesDenmark
In The Last Decade
Guoli Sun
48 papers receiving 1.0k citations
Guoli Sun's Hit Papers
Peers
Comparison fields: 5 of 107
- Nephrology 150
- Pharmacology 227
- Virology 57
- Pharmacology 89
- Cancer Research 128
Countries citing papers authored by Guoli Sun
This map shows the geographic impact of Guoli Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guoli Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guoli Sun more than expected).
Fields of papers citing papers by Guoli Sun
This network shows the impact of papers produced by Guoli Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guoli Sun. The network helps show where Guoli Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Guoli Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension Hit paper breakdown → | 2014 | 368 |
| 2 | 2015 | 87 | |
| 3 | 2014 | 72 | |
| 4 | 2002 | 66 | |
| 5 | 2021 | 61 | |
| 6 | 2018 | 47 | |
| 7 | 2017 | 32 | |
| 8 | 2019 | 22 | |
| 9 | 2017 | 21 | |
| 10 | 2020 | 20 | |
| 11 | 2019 | 18 | |
| 12 | 2019 | 15 | |
| 13 | 2021 | 12 | |
| 14 | 2001 | 11 | |
| 15 | 2022 | 10 | |
| 16 | 2021 | 10 | |
| 17 | 2019 | 10 | |
| 18 | 2020 | 10 | |
| 19 | 2019 | 10 | |
| 20 | 2019 | 10 |
About Guoli Sun
Guoli Sun is a scholar working on Nephrology, Molecular Biology, Cancer Research, Critical Care and Intensive Care Medicine and Pulmonary and Respiratory Medicine, having authored 53 papers that have together received 1.0k indexed citations. Recurring topics across this work include Acute Kidney Injury Research (20 papers), Trauma, Hemostasis, Coagulopathy, Resuscitation (3 papers), Cardiac Imaging and Diagnostics (2 papers), Cancer Genomics and Diagnostics (2 papers), Chronic Kidney Disease and Diabetes (2 papers), HIV/AIDS drug development and treatment (2 papers), Systemic Lupus Erythematosus Research (2 papers) and Systemic Sclerosis and Related Diseases (2 papers). The work is most often cited by research in Nephrology (150 citations), Pharmacology (227 citations), Virology (57 citations), Pharmacology (89 citations) and Cancer Research (128 citations). Guoli Sun has collaborated with scholars based in China, United States and Denmark. Frequent co-authors include Wenjie Zheng, Jiarong Lan, Feixia Dong, Yanyun Zhao, Yong Liu, Shiqun Chen, Jiyan Chen, Jin Liu, Joseph P. Dougherty and Hong Yu. Their work appears in journals such as Annals of Translational Medicine, BMC Cardiovascular Disorders, Journal of Internal Medicine, Trials and BMJ Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.